Cyramza 500 mg/50 mL (10 mg/mL) injection Images
Generic Name: ramucirumab
This medication has been identified as Cyramza 500 mg/50 mL (10 mg/mL) injection. It is supplied by Eli Lilly and Company.
Cyramza is used in the treatment of Colorectal Cancer; Gastric Cancer; Hepatocellular Carcinoma; Non-Small Cell Lung Cancer; Stomach Cancer and belongs to the drug class VEGF/VEGFR inhibitors. Risk cannot be ruled out during pregnancy. Cyramza 500 mg/50 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
More about Cyramza (ramucirumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: VEGF/VEGFR inhibitors
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.